Changing profile of rotavirus genotypes in Bangladesh, 2006-2012

BMC Infect Dis. 2013 Jul 15:13:320. doi: 10.1186/1471-2334-13-320.

Abstract

Background: Rotavirus is the leading cause of severe diarrhea in infants and young children worldwide including Bangladesh. Unlike what was seen in high-income countries, the licensed rotavirus vaccines did not show high efficacy in Bangladeshi trials. We assessed rotavirus prevalence and genotypes in Bangladesh over six-year period to provide baseline information on the rotavirus burden and changing profile in the country.

Methods: This study was conducted from June 2006 to May 2012 in Matlab, Bangladesh. Group A rotaviruses were detected in stools collected from diarrhea patients by ELISA and genotyped using multiplex reverse transcription PCR followed by nucleotide sequencing.

Results: Of the 9678 stool samples, 20.3% were positive for rotavirus. The most predominant genotype was G1P[8] (22.4%), followed by G9P[8] (20.8%), G2P[4] (16.9%) and G12P[8] (10.4%). Mixed infections were detected in 14.2% of the samples. Emergence of an unusual strain, G9P[4] was documented during 2011-12. Several amino acid mismatches in the antigenic epitopes of VP7 and VP4 between Bangladeshi and the vaccine strains were identified.

Conclusions: Our study provides important information on rotavirus genotypes that should be considered for the selection and introduction of rotavirus vaccines in Bangladesh.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Amino Acid Substitution
  • Antigens, Viral / immunology
  • Bangladesh / epidemiology
  • Diarrhea / epidemiology
  • Diarrhea / virology
  • Feces / virology
  • Genotype
  • Humans
  • Molecular Sequence Data
  • Prospective Studies
  • Rotavirus / genetics*
  • Rotavirus / immunology
  • Rotavirus / isolation & purification
  • Rotavirus Infections / epidemiology
  • Rotavirus Infections / virology*
  • Rotavirus Vaccines / administration & dosage
  • Rotavirus Vaccines / immunology

Substances

  • Antigens, Viral
  • Rotavirus Vaccines